Free Trial

RXO (NYSE:RXO) Price Target Cut to $15.00 by Analysts at Citigroup

RXO logo with Transportation background
Remove Ads

RXO (NYSE:RXO - Free Report) had its price objective reduced by Citigroup from $23.00 to $15.00 in a research report sent to investors on Tuesday morning,Benzinga reports. Citigroup currently has a neutral rating on the stock.

RXO has been the topic of several other reports. Oppenheimer downgraded shares of RXO from an "outperform" rating to a "market perform" rating in a research note on Friday, April 4th. Stifel Nicolaus lowered their target price on RXO from $27.00 to $24.00 and set a "hold" rating on the stock in a report on Thursday, February 6th. Morgan Stanley cut their price target on RXO from $27.00 to $25.00 and set an "equal weight" rating for the company in a report on Thursday, February 6th. Deutsche Bank Aktiengesellschaft started coverage on RXO in a research note on Friday, March 7th. They set a "hold" rating and a $19.00 price objective on the stock. Finally, Jefferies Financial Group cut their target price on RXO from $33.00 to $30.00 and set a "buy" rating for the company in a research note on Friday, January 10th. Two research analysts have rated the stock with a sell rating, twelve have given a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $22.73.

Get Our Latest Analysis on RXO

RXO Price Performance

RXO stock traded down $0.45 during midday trading on Tuesday, reaching $13.62. The company had a trading volume of 1,586,882 shares, compared to its average volume of 1,097,140. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.26 and a quick ratio of 1.33. RXO has a 12-month low of $12.39 and a 12-month high of $32.82. The company has a market capitalization of $2.23 billion, a P/E ratio of -6.43, a P/E/G ratio of 4.55 and a beta of 1.60. The firm's fifty day simple moving average is $18.83 and its 200-day simple moving average is $24.29.

Remove Ads

RXO (NYSE:RXO - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $0.06 earnings per share for the quarter, meeting the consensus estimate of $0.06. RXO had a positive return on equity of 1.53% and a negative net margin of 6.26%. As a group, equities analysts anticipate that RXO will post 0.31 EPS for the current year.

Institutional Investors Weigh In On RXO

A number of institutional investors have recently modified their holdings of RXO. Wilmington Savings Fund Society FSB purchased a new position in RXO during the 3rd quarter valued at about $28,000. Blue Trust Inc. boosted its stake in shares of RXO by 79.7% in the fourth quarter. Blue Trust Inc. now owns 1,150 shares of the company's stock valued at $27,000 after purchasing an additional 510 shares during the period. Smartleaf Asset Management LLC grew its holdings in shares of RXO by 228.4% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,248 shares of the company's stock valued at $30,000 after purchasing an additional 868 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its stake in RXO by 68.7% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company's stock worth $39,000 after buying an additional 570 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. lifted its holdings in RXO by 407.0% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company's stock worth $43,000 after buying an additional 1,445 shares in the last quarter. 92.73% of the stock is owned by institutional investors and hedge funds.

RXO Company Profile

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

See Also

Analyst Recommendations for RXO (NYSE:RXO)

Should You Invest $1,000 in RXO Right Now?

Before you consider RXO, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.

While RXO currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads